Evidence & regulatory context
- Mechanism
- Biologic (EphA4-Fc recombinant fusion protein), preclinical; no matching trial identified
- Target
- Not recorded
- Injury models
- Spinal cord injury
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatSpinal cord injuryContusionWistarFemaleAcute delivery after contusion
Model: Thoracic contusive spinal cord injury
EphA4-Fc significantly improved recovery of locomotor function and increased the cross-sectional area of the dorsal funiculus caudal to the injury epicentre compared with controls.
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.
